...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Gilead GS-5829 Perspective

Hi TADA,

 

In my mind what your saying if true that someone is still alive after one year on zen3694  who was suppose to die  that is newsworthy IMO!!  if so why the secrecy from managment unless your negotiating out a deal with BP  but I have that a million times and still disappointed!

Share
New Message
Please login to post a reply